The emerging potential of siRNA nanotherapeutics in treatment of arthritis
RNA interference (RNAi) using small interfering RNA (siRNA) has shown potential as a therapeutic option for the treatment of arthritis by silencing specific genes. However, siRNA delivery faces several challenges, including stability, targeting, off-target effects, endosomal escape, immune response...
Saved in:
Main Authors: | Anjali Kumari (Author), Amanpreet Kaur (Author), Geeta Aggarwal (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
by: Dima Hattab, et al.
Published: (2021) -
Increasing angiogenesis factors in hypoxic diabetic wounds using siRNA nanotherapeutics
by: Adam Astrada
Published: (2024) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
siRNA Targeting and Treatment of Gastrointestinal Diseases
by: Rachel Chevalier
Published: (2019)